← Explorer/Network

Regional metabolic patterns in mild cognitive impairment and Alzheimer’s disease

Kantarci K, Jack CR, Xu YC +8 more2000NeurologyJournal Article
10.1212/wnl.55.2.210PubMedFree full text

Abstract

BACKGROUND: Mild cognitive impairment (MCI) is a recently described transitional clinical state between normal aging and AD. Assuming that amnestic MCI patients had pathologic changes corresponding to an early phase and probable AD patients to a later phase of the disease progression, the authors could approximate the temporal course of proton MR spectroscopic (1H MRS) alterations in AD with a cross-sectional sampling scheme. METHODS: The authors compared 1H MRS findings in the superior temporal lobe, posterior cingulate gyri, and medial occipital lobe in 21 patients with MCI, 21 patients with probable AD, and 63 elderly controls. These areas are known to be involved at different neurofibrillary pathologic stages of AD. RESULTS: The N-acetylaspartate (NAA)/creatine (Cr) ratios were significantly lower in AD patients compared to both MCI and normal control subjects in the left superior temporal and the posterior cingulate volumes of interest (VOI) and there were no between-group differences in the medial occipital VOI. Myoinositol (MI)/Cr ratios measured from the posterior cingulate VOI were significantly higher in both MCI and AD patients than controls. The choline (Cho)/Cr ratios measured from the posterior cingulate VOI were higher in AD patients compared to both MCI and control subjects. CONCLUSION: These findings suggest that the initial 1H MRS change in the pathologic progression of AD is an increase in MI/Cr. A decrease in NAA/Cr and an increase in Cho/Cr develop later in the disease course.

Cited By (12)

  • Cognitive impairment: classification by 1H magnetic resonance spectroscopyEuropean Journal of Neurology · 2004
  • Brain metabolites and cognitive function among older depressed and healthy individuals using 2D MR spectroscopyNeuropsychopharmacology · 2004
  • MR Spectroscopy in Neurodegenerative diseaseMolecular Imaging and Biology · 2007
  • Evidence of biochemical and biomagnetic interactions in Alzheimer’s disease: an MEG and MR spectroscopy studyDementia and Geriatric Cognitive Disorders · 2005
  • A multicenter reproducibility study of single-voxel 1H-MRS of the medial temporal lobeEuropean Radiology · 2006
  • Longitudinal changes during aging using proton magnetic resonance spectroscopyThe Journals of Gerontology Series A · 2006
  • Effects of Alzheimer Disease on Fronto-parietal Brain N-acetyl Aspartate and Myo-Inositol Using Magnetic Resonance Spectroscopic Imaging
Alzheimer Disease & Associated Disorders · 2006
  • MR spectroscopy of brain white matter in the prediction of dementiaNeurology · 2006
  • MRS shows abnormalities before symptoms in familial Alzheimer diseaseNeurology · 2006
  • Relationships between astrogliosis and 1H MR spectroscopic measures of brain choline/creatine in a primate modelPubMed · 2005
  • Neuroimaging in Alzheimer disease: an evidence-based reviewNeuroimaging Clinics of North America · 2003
  • Proton MR spectroscopy in mild cognitive impairment and Alzheimer disease: a comparison of 1.5 and 3 TPubMed · 2003